CannHM. Human genome diversity. Comptes Rendus de l'Academie des Sciences. Serie III: Sciences de la Vie1998; 32:443–6.
2.
WeberWW. Populations and genetic polymorphisms. Mol Diagn1999; 4:299–307.
3.
GarteSGaspariLAlexandrieAKAmbrosoneCAutrupHAutrupJL, Metabolic gene frequencies in control populations. Cancer Epidemiol Biomarkers Prev2001; 10:1239–48.
4.
ShepherdTTolbertDBenedettiJMacdonaldJStemmermannGWiestJ, Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology2000; 118:1039–44.
5.
LampeJWBiglerJHornerNKPotterJD. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: Relationships to serum bilirubin concentrations. Pharmacogenetics1999; 9:341–9.
6.
SchaeffelerEEichelbaumMBrinkmannUPengerAAsante-PokuSZangerUMSchwabM. Frequency of C3435T polymorphism of MDR1 gene in African people. Lancet2001; 358:383–4.
7.
BaerwaldCGMokCCFifeMSTiklyMLauCSWordsworthBP, Distribution of corticotropin-releasing hormone promoter polymorphism in different ethnic groups: Evidence for natural selection in human populations. Immunogenetics1999; 49:894–9.
8.
DeanMStephensJCWinklerCLombDARamsburgMBoazeR, Polymorphic admixture typing in human ethnic populations. Am J Hum Genet1994; 55:788–808.
9.
WhitfieldLSSulstonJEGoodfellowPN. Sequence variation of the human Y chromosome. Nature1995; 378:379–80.
10.
Cavalli-SforzaLLMenozziPPiazzaA. The history and geography of human genes. Princeton: Princeton University Press; 1994.
11.
RelethfordJH. Genetics and the search for modern human origins. New York: Wiley-Liss; 2001.
12.
MountainJLCavalli-SforzaLL. Multilocus genotypes, a tree of individuals, and human evolutionary history. Am J Hum Genet1997; 61:705–18.
13.
WilsonJFWealeMESmithACGratrixFFletcherBThomasMG, Population genetic structure of variable drug response. Nat Genet2001; 29:265–9.
14.
GarteS. The role of ethnicity in cancer susceptibility gene polymorphisms: The example of CYP1A1. Carcinogenesis1998; 19:1329–32.
15.
Ingelman-SundbergM. Genetic variability in susceptibility and response to toxicants. Toxicol Lett2001; 120:259–68.
16.
DysonSM. “Race,” ethnicity and haemoglobin disorders. Soc Sci Med1998; 47:121–31.
17.
StephensJCSchneiderJATanguayDAChoiJAcharyaTStanleySE, Haplotype variation and linkage disequilibrium in 313 human genes. Science2001; 293:489–93.
18.
MasoudiFAHavranekEP. Race and responsiveness to drugs for heart failure. N Engl J Med2001; 345:767.
19.
ExnerDVDriesDLDomanskiMJCohnJN. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med2001; 344:1351–7.